Affordable Access

Treatment of hypercholesterolemia with ezetimibe in the kidney transplant population.

Authors
  • Puthenparumpil, J J
  • Keough-Ryan, T
  • Kiberd, M
  • Lawen, J
  • Kiberd, B A
Type
Published Article
Journal
Transplantation Proceedings
Publisher
Elsevier
Publication Date
Mar 01, 2005
Volume
37
Issue
2
Pages
1033–1035
Identifiers
PMID: 15848614
Source
Medline
License
Unknown

Abstract

Ezetimibe is an effective LDL cholesterol-lowering agent in the kidney transplant population. Further studies are warranted in a larger population not only to examine the extent of cardiovascular risk reduction but also to detect unwarranted toxicity.

Report this publication

Statistics

Seen <100 times